NetworkNewsBreaks – Earth Science Tech, Inc. (ET
Post# of 333
Science-based biotechnology company Earth Science Tech, Inc. (OTC: ETST) recently signed an agreement with a private laboratory for clinical studies related to its MSN-2 medical device. “We are on the cusp of making tremendous progress in our clinical trial efforts,” Dr. Michel Aubé, CEO and CSO of ETST, stated in a news release. An article discussing the agreement reads: “ETST now has the laboratory partner needed to support the company’s research and development efforts, along with the commercialization of its MSN-2 medical device, which has been specifically developed to support women’s health and the related molecular diagnostics to which women desperately need access, Aubé said.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer